Watch Live: EMA Delivers Update On AstraZeneca Jab After Acknowledging Blood-Clot Link


Update (0955ET): In a statement released just minutes before the briefing’s start, the EMA declared that it had found a possible link between the extremely rare blood clots and the AstraZeneca jab – however, these risks are still heavily outweighed by the societal benefits.

  • EMA FINDS POSSIBLE LINK TO VERY RARE CASES UNUSUAL BLOOD CLOTS
  • EMA CONFIRMS TOTAL BENEFIT-RISK REMAINS POSITIVE ON ASTRA SHOT
  • EMA: SPECIFIC RISK FACTORS NOT CONFIRMED FOR WOMEN UNDER 60
  • MOST CASES REPORTED WITHIN 2 WEEKS OF VACCINATION
  • IMMUNE RESPONSE ONE POSSIBLE EXPLANATION
  • EMA: COMBINATION OF BLOOD CLOTS AND LOW BLOOD PLATELETS IS RARE

* * *

Weeks after its initial “safety review”, where the EMA insisted that the risks posed by the AstraZeneca jab were outweighed by the massive societal benefit, dozens of new cases of blood clots have been detected, including 25 in the UK that have apparently been linked to the jab. The news prompted Oxford to cancel a trial of the vaccine involving young children. Yesterday, the EMA finally acknowledged that there might indeed be a link between the jab and the clots, but that it wasn’t very clear.

Wednesday is “World Health Day”, yet two regions in Spain have just announced new plans to suspend AstraZeneca shots to patients under 65, pending further clarification from the EMA.

“EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Vaxzevria (formerly Covid-19 Vaccine AstraZeneca) relating to cases of thromboembolic events by EMA’s safety committee,” the agency said in a statement.

A few days ago, an Australian official ackowledged that a link between the jab and the brain blood clots were extremely like.

Readers can watch the briefing live below:





Source link

Comment box